Fund: GLOGB
| Global X Genomics & Biotechnology ETF (dis) | |
| US37954Y4347 | |
| 05-04-2019 | |
| Equity | |
| Equity Sectors - Health Care | |
| Global X Funds | |
| Global X Management Company LLC | |
| USD | |
| 1,000 | |
| 5% |
| 1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Výkonnosť fondu | -13.65% | -9.65% | 4.03% | -20.16% | -21.01% | -23.95% | -7.01% | - | - | N/A | |
| Priemerná výkonnosť (36 meraní) | -1.54% | -12.73% | - | - | - | ||||||
| Volatilita od priemernej výkonnosti | 13.46% | 44.34% | - | - | - |
| Long | Short | Net | |
|---|---|---|---|
| Stock | 100.02% | 100.02% | |
| Bond | |||
| Other | |||
| Cash | 0.02% | -0.02% |
| Aktíva | 1,036 mil. |
| Počet akcíí | 41 |
| Počet dlhopisov | 0 |
| Priebež. popl. | |
| z toho Mng. popl. | 0.50 |
| Výk. prémia | |
| Trans. popl. |
| Dividenda | 0.013 |
| Dividendový výnos | 0.13% |
| Rozhodný dátum | 30-12-2021 |
| Frekvencia výplaty | polročne |
| Giant | 0.00% |
| Large | 6.49% |
| Medium | 40.24% |
| Small | 25.23% |
| Micro | 25.19% |
| P/E | 35.77% |
| P/BV | 3.13% |
| Healthcare | 100.02% |
| Derivatives | -0.02 |
| Výnos do splatnosti p.a. | |
| Modifikovaná durácia |
| United States | 90.38% |
| Canada | |
| Latin America | |
| United Kingdom | |
| Eurozone | 3.56% |
| Europe - ex Euro | 5.54% |
| Europe - Emerging | |
| Africa | |
| Middle East | |
| Japan | 0.53% |
| Australasia | |
| Asia - Developed | |
| Asia - Emerging | |
| Emerging Market | |
| Developed Country | 100.02% |
| Not Classified |
| Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
|---|---|---|---|---|---|
| Natera Inc | Healthcare | 7.7% | CRISPR Therapeutics AG | Healthcare | 5.54% |
| Ultragenyx Pharmaceutical Inc | Healthcare | 4.79% | Agilent Technologies Inc | Healthcare | 4.56% |
| Moderna Inc | Healthcare | 4.45% | Sarepta Therapeutics Inc | Healthcare | 3.92% |
| Illumina Inc | Healthcare | 3.7% | Bio-Techne Corp | Healthcare | 3.65% |
| Arrowhead Pharmaceuticals Inc | Healthcare | 3.63% | Beam Therapeutics Inc | Healthcare | 3.62% |